Gタンパク質共役型受容体市場：製品タイプ別、アッセイタイプ別、用途別-2025-2030年の世界予測

Gタンパク質共役型受容体市場は、2023年に33億1,000万米ドルと評価され、2024年には35億1,000万米ドルに達すると予測され、CAGR 6.27％で成長し、2030年には50億7,000万米ドルになると予測されています。

Gタンパク質共役型受容体（GPCR）は、多くの生理的プロセスにおいて重要な細胞表面受容体の広大なファミリーであり、創薬および薬剤開発に不可欠なものとなっています。GPCR市場の範囲は、医薬品、バイオテクノロジー、学術部門を包含しており、がん、心血管障害、神経疾患などの幅広い疾患の治療にその役割が必要とされています。ハイスループット・スクリーニング技術と高度な計算モデリングにより、GPCRの機能のより正確なターゲティングと理解が可能になり、創薬と個別化医療への応用が強化されています。最終用途分野には主に製薬会社、研究機関、受託研究機関が含まれます。市場の成長は主に、慢性疾患の有病率の上昇、研究開発投資の増加、ゲノミクスとプロテオミクスの技術進歩によってもたらされます。人工知能や機械学習とGPCR調査の統合は、より予測的で的を絞った治療への機会を提供し、個別化医療や新規治療アプローチへの道を開く。このような機会にもかかわらず、市場は研究開発に伴う高コスト、複雑な規制要件、GPCR構造の理解における技術的限界といった課題に直面しています。さらに、高い競合や専門人材の必要性も成長の妨げとなります。このような障害を克服する戦略としては、学界と産業界の共同努力、基礎研究への資金提供の増加、技術共有のためのパートナーシップの育成などが挙げられます。構造ベースの薬物設計とアロステリックモジュレーションにおける革新は、事業成長の有望分野です。全体として、GPCR市場はダイナミックに拡大しており、受容体の機能を包括的に理解することが、その可能性を活用する上で不可欠です。イノベーション、戦略的提携、適応性のある規制状況を優先する企業は、この進化する状況の中で大きな利益を得ることができると思われます。

市場力学：急速に進化するGタンパク質共役型受容体市場の主要市場インサイトを公開

Gタンパク質共役型受容体市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の心血管疾患の増加
  • 新規医薬品および治療法の開発への支出の増加
  • がんの負担を軽減するための継続的な研究活動
• 市場抑制要因
  • Gタンパク質共役型受容体（GPCR）に関連する高コスト
• 市場機会
  • 新規医薬品・治療法の承認件数の急増
  • Gタンパク質共役型受容体の分子理解の新たな進展
• 市場の課題
  • 厳しい承認基準と相まって、熟練した専門家や訓練された被験者の専門知識の不足

ポーターのファイブフォース：Gタンパク質共役型受容体市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：Gタンパク質共役型受容体市場における外部からの影響の把握

外部マクロ環境要因は、Gタンパク質共役型受容体市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析Gタンパク質共役型受容体市場における競合情勢の把握

Gタンパク質共役型受容体市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスGタンパク質共役型受容体市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、Gタンパク質共役型受容体市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨Gタンパク質共役型受容体市場における成功への道筋を描く

Gタンパク質共役型受容体市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大の可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で心血管疾患が増加
    • 新しい医薬品や治療法の開発への支出の増加
    • がんの負担を軽減するための継続的な調査活動
  • 抑制要因
    • Gタンパク質共役型受容体（GPCR）に関連する高コスト
  • 機会
    • 新薬や治療法の規制承認件数の急増
    • Gタンパク質共役受容体の分子的理解における新たな進歩
  • 課題
    • 熟練した専門家や訓練された主題の専門知識の不足と厳格な承認基準
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 Gタンパク質共役型受容体市場：製品別

• 細胞培養試薬
• 細胞株
• 検出キット
• リガンド

第7章 Gタンパク質共役型受容体市場アッセイタイプ別

• カルシウム機能アッセイ
• cAMP機能アッセイ
• 内在化アッセイ
• 放射性リガンド結合およびGTPYS機能アッセイ
• 輸送アッセイ
• B-アレスチン機能アッセイ

第8章 Gタンパク質共役型受容体市場：用途別

• がん調査
• 心臓血管調査
• 中枢神経系調査
• 炎症調査
• 代謝調査
• 呼吸器調査

第9章 南北アメリカのGタンパク質共役型受容体市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のGタンパク質共役型受容体市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのGタンパク質共役型受容体市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abalone Bio, Inc.
• Abcam PLC
• Addex Therapeutics
• Becton, Dickinson and Company
• BioInvenu,Inc.
• Cisbio Bioassays SAS
• Confo Therapeutics
• Corning Incorporated
• Crinetics Pharmaceuticals, Inc.
• Domain Therapeutics SA
• Enzo Life Sciences, Inc.
• Escient Pharmaceuticals
• Eurofins Scientific SE
• Merck KGaA
• Molecular Devices, LLC
• OKYO Pharma, Limited
• Orion Biotechnology
• OSE Immunotherapeutics
• PerkinElmer Inc.
• Promega Corporation
• QIAGEN GmbH
• Septerna
• Sosei Group Corporation
• Tectonic Therapeutic
• Teon Therapeutics, Inc.
• Thermo Fisher Scientific Inc.
• WuXi AppTec

LIST OF FIGURES

• FIGURE 1. G-PROTEIN COUPLED RECEPTORS MARKET RESEARCH PROCESS
• FIGURE 2. G-PROTEIN COUPLED RECEPTORS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. G-PROTEIN COUPLED RECEPTORS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. G-PROTEIN COUPLED RECEPTORS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. G-PROTEIN COUPLED RECEPTORS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. G-PROTEIN COUPLED RECEPTORS MARKET DYNAMICS
• TABLE 7. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CELL CULTURE REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY DETECTION KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY LIGANDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CALCIUM FUNCTIONAL ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CAMP FUNCTIONAL ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY INTERNALIZATION ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RADIOLIGAND BINDING AND GTPS FUNCTIONAL ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY TRAFFICKING ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY B-ARRESTIN FUNCTIONAL ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CARDIOVASCULAR RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY CNS RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY INFLAMMATION RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY METABOLIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY RESPIRATORY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. CANADA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. CANADA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. CANADA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. CHINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. CHINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. CHINA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. INDIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. INDIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. INDIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. INDONESIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. INDONESIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. INDONESIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. JAPAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. JAPAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. JAPAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. MALAYSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. MALAYSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. MALAYSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. PHILIPPINES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. PHILIPPINES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. PHILIPPINES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. SINGAPORE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. SINGAPORE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. SINGAPORE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. SOUTH KOREA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. SOUTH KOREA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. SOUTH KOREA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. TAIWAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. TAIWAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. TAIWAN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. THAILAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. THAILAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. THAILAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. VIETNAM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. VIETNAM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. VIETNAM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. EUROPE, MIDDLE EAST & AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 90. DENMARK G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. DENMARK G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. DENMARK G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. EGYPT G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. EGYPT G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. EGYPT G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. FINLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. FINLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. FINLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. FRANCE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. FRANCE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. FRANCE G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. GERMANY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. GERMANY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. GERMANY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. ISRAEL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. ISRAEL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. ISRAEL G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. ITALY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. ITALY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. ITALY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. NETHERLANDS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. NETHERLANDS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. NETHERLANDS G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. NIGERIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. NIGERIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. NIGERIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. NORWAY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. NORWAY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. NORWAY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. POLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. POLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. POLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. QATAR G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. QATAR G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. QATAR G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. RUSSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. RUSSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. RUSSIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SAUDI ARABIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. SAUDI ARABIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SAUDI ARABIA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. SOUTH AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SOUTH AFRICA G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SPAIN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. SPAIN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. SPAIN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. SWEDEN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. SWEDEN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. SWEDEN G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. SWITZERLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. SWITZERLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. SWITZERLAND G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. TURKEY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. TURKEY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. TURKEY G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. UNITED ARAB EMIRATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. UNITED ARAB EMIRATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 149. UNITED ARAB EMIRATES G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. UNITED KINGDOM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 151. UNITED KINGDOM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 152. UNITED KINGDOM G-PROTEIN COUPLED RECEPTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. G-PROTEIN COUPLED RECEPTORS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 154. G-PROTEIN COUPLED RECEPTORS MARKET, FPNV POSITIONING MATRIX, 2023

The G-Protein Coupled Receptors Market was valued at USD 3.31 billion in 2023, expected to reach USD 3.51 billion in 2024, and is projected to grow at a CAGR of 6.27%, to USD 5.07 billion by 2030.

G-Protein Coupled Receptors (GPCRs) are a vast family of cell surface receptors crucial in many physiological processes, making them vital in drug discovery and development. The GPCR market's scope encompasses pharmaceuticals, biotechnology, and the academic sector, necessitated by its role in treating a wide array of diseases such as cancer, cardiovascular disorders, and neurological conditions. The high-throughput screening techniques and advanced computational modeling have enabled more precise targeting and understanding of GPCR functions, thereby enhancing applications in drug discovery and personalized medicine. End-use segments mainly include pharmaceutical companies, research institutions, and contract research organizations. Market growth is primarily driven by the rising prevalence of chronic diseases, increasing investment in research and development, and technological advancements in genomics and proteomics. The integration of artificial intelligence and machine learning with GPCR research offers opportunities for more predictive and targeted therapies, paving the way for personalized medicine and novel therapeutic approaches. Despite these opportunities, the market faces challenges such as high costs associated with R&D, complex regulatory requirements, and technical limitations in understanding GPCR structures. Moreover, the high competition and need for specialized personnel can also impede growth. Strategies to overcome these obstacles include collaborative efforts between academia and industry, increased funding for basic research, and fostering partnerships for technology sharing. Innovations in structure-based drug design and allosteric modulation represent promising areas for business growth. Overall, the GPCR market is dynamic and expanding, with a comprehensive understanding of receptor functions being integral to harnessing its potential. Companies that prioritize innovation, strategic collaborations, and adaptive regulatory strategies stand to benefit significantly in this evolving landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving G-Protein Coupled Receptors Market

The G-Protein Coupled Receptors Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising number of cardiovascular diseases across the globe
  • Increasing expenditure for the development of novel pharmaceutical drugs and therapies
  • Ongoing research activities to reduce the cancer burden
• Market Restraints
  • Associated high cost with G-protein coupled receptors (GPCRs)
• Market Opportunities
  • Surge in the number of regulatory approvals for novel drugs and therapies
  • Emerging advances in the molecular understanding of G protein-coupled receptors
• Market Challenges
  • Lack of skilled professionals or trained subject expertise coupled with stringent approval norms

Porter's Five Forces: A Strategic Tool for Navigating the G-Protein Coupled Receptors Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the G-Protein Coupled Receptors Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the G-Protein Coupled Receptors Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the G-Protein Coupled Receptors Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the G-Protein Coupled Receptors Market

A detailed market share analysis in the G-Protein Coupled Receptors Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the G-Protein Coupled Receptors Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the G-Protein Coupled Receptors Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the G-Protein Coupled Receptors Market

A strategic analysis of the G-Protein Coupled Receptors Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the G-Protein Coupled Receptors Market, highlighting leading vendors and their innovative profiles. These include Abalone Bio, Inc., Abcam PLC, Addex Therapeutics, Becton, Dickinson and Company, BioInvenu,Inc., Cisbio Bioassays SAS, Confo Therapeutics, Corning Incorporated, Crinetics Pharmaceuticals, Inc., Domain Therapeutics SA, Enzo Life Sciences, Inc., Escient Pharmaceuticals, Eurofins Scientific SE, Merck KGaA, Molecular Devices, LLC, OKYO Pharma, Limited, Orion Biotechnology, OSE Immunotherapeutics, PerkinElmer Inc., Promega Corporation, QIAGEN GmbH, Septerna, Sosei Group Corporation, Tectonic Therapeutic, Teon Therapeutics, Inc., Thermo Fisher Scientific Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the G-Protein Coupled Receptors Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Cell Culture Reagents, Cell Lines, Detection Kits, and Ligands.
• Based on Assay Type, market is studied across Calcium Functional Assays, cAMP Functional Assays, Internalization Assays, Radioligand Binding and GTPYS Functional Assays, Trafficking Assays, and B-Arrestin Functional Assays.
• Based on Application, market is studied across Cancer Research, Cardiovascular Research, CNS Research, Inflammation Research, Metabolic Research, and Respiratory Research.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising number of cardiovascular diseases across the globe
    • 5.1.1.2. Increasing expenditure for the development of novel pharmaceutical drugs and therapies
    • 5.1.1.3. Ongoing research activities to reduce the cancer burden
  • 5.1.2. Restraints
    • 5.1.2.1. Associated high cost with G-protein coupled receptors (GPCRs)
  • 5.1.3. Opportunities
    • 5.1.3.1. Surge in the number of regulatory approvals for novel drugs and therapies
    • 5.1.3.2. Emerging advances in the molecular understanding of G protein-coupled receptors
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of skilled professionals or trained subject expertise coupled with stringent approval norms
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. G-Protein Coupled Receptors Market, by Product

• 6.1. Introduction
• 6.2. Cell Culture Reagents
• 6.3. Cell Lines
• 6.4. Detection Kits
• 6.5. Ligands

7. G-Protein Coupled Receptors Market, by Assay Type

• 7.1. Introduction
• 7.2. Calcium Functional Assays
• 7.3. cAMP Functional Assays
• 7.4. Internalization Assays
• 7.5. Radioligand Binding and GTPYS Functional Assays
• 7.6. Trafficking Assays
• 7.7. B-Arrestin Functional Assays

8. G-Protein Coupled Receptors Market, by Application

• 8.1. Introduction
• 8.2. Cancer Research
• 8.3. Cardiovascular Research
• 8.4. CNS Research
• 8.5. Inflammation Research
• 8.6. Metabolic Research
• 8.7. Respiratory Research

9. Americas G-Protein Coupled Receptors Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific G-Protein Coupled Receptors Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa G-Protein Coupled Receptors Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abalone Bio, Inc.
• 2. Abcam PLC
• 3. Addex Therapeutics
• 4. Becton, Dickinson and Company
• 5. BioInvenu,Inc.
• 6. Cisbio Bioassays SAS
• 7. Confo Therapeutics
• 8. Corning Incorporated
• 9. Crinetics Pharmaceuticals, Inc.
• 10. Domain Therapeutics SA
• 11. Enzo Life Sciences, Inc.
• 12. Escient Pharmaceuticals
• 13. Eurofins Scientific SE
• 14. Merck KGaA
• 15. Molecular Devices, LLC
• 16. OKYO Pharma, Limited
• 17. Orion Biotechnology
• 18. OSE Immunotherapeutics
• 19. PerkinElmer Inc.
• 20. Promega Corporation
• 21. QIAGEN GmbH
• 22. Septerna
• 23. Sosei Group Corporation
• 24. Tectonic Therapeutic
• 25. Teon Therapeutics, Inc.
• 26. Thermo Fisher Scientific Inc.
• 27. WuXi AppTec